追加説明:
PT. Fonko International Pharmaceuticals offers a broad range of oncology finished dosage forms, including bortezomib at 1 mg and 3.5 mg strengths, indicated for multiple myeloma and mantle cell lymphoma; further information is available on request.
評価とコメントを残す